High importance
Oct 2, 2026
Understanding the growth patterns and risk of hemorrhage in bAVMs among HHT patients can inform clinical management and surveillance strategies, potentially reducing unnecessary imaging and interventions in patients with a benign course.
To evaluate the natural history and growth patterns of brain arteriovenous malformations (bAVMs) in patients with Hereditary Hemorrhagic Telangiectasia (HHT) through a longitudinal study using serial MRIs.
Out of 12 patients analyzed, 10 had micro-bAVMs and none exhibited growth over time. Two patients with larger bAVMs (nidus >1 cm) showed an average growth rate of 1.61 mm/year. No incidence of bAVM rupture was reported during the study period of 4.15 years or a cumulative follow-up of 49.78 patient years.
Conducted a retrospective analysis of 44 patients from an HHT Center of Excellence over a 10-year period. Included patients who had serial MRIs showing radiographic bAVMs. Primary outcomes measured included growth of bAVMs and secondary outcomes included hemorrhage from rupture.
Limited sample size may affect generalizability. The follow-up period may not capture long-term outcomes in a broader patient population. The nature of a retrospective study can introduce selection bias.
For your doctor:
PMID: 42825815
DOI: 10.1007/s00234-026-04208-0
PURPOSE: The natural history of brain arteriovenous malformations (bAVMs) in Hereditary Hemorrhagic Telangiectasia (HHT) remains poorly understood and it has been suggested that they may have a benign course different from sporadic bAVMs. Here, we present a single-center longitudinal study evaluating the growth of bAVMs over time as assessed by serial MRIs. METHODS: We performed a retrospective analysis of 44 patients with suspected bAVMs followed at an HHT Center of Excellence from 2014 to 2024. We excluded patients that did not have serial MRIs and/or poor-quality MRIs, and patients without radiographic bAVMs. Primary outcome was growth of bAVM as measured by largest dimension on T1 post-contrasted weighted sequences of serial MRIs. Secondary outcome was hemorrhage from bAVM rupture. RESULTS: Twelve patients (3 male, 9 female) met our criteria. Average age at first MRI was 39.9 years (range 6-65 years). Ten patients had micro-bAVMs and 3/10 of these patients had multiple micro-bAVMs. None of the micro-bAVMs showed any growth on serial MRIs. The other two patients in our study had bAVMs with niduses > 1 cm and showed an average rate of growth of 1.61 mm/year. Ultimately, none of our patients had rupture of bAVMs over an average radiographic follow-up of 4.15 years and a total of 49.78 patient years. CONCLUSION: Our study suggests that bAVMs in HHT patients may have a benign natural history. We found no hemorrhages and noted minimal growth of bAVMs on serial MRIs. Our results suggest HHT patients with bAVMs may not warrant frequent surveillance imaging.